News Leading US Neuroscientist appointed Chief Scientific Officer of LCT BioPharma LCT announced that Dwaine F. Emerich has been appointed Chief Scientific Officer of LCT BioPharma Inc. Dr Emerich, a highly regarded and experienced scientist has been with LCT's US operations as Vice-President of Research since 2003. He joined the company from Sertoli Technologies Inc where he led the company's research efforts to develop and commercialise Sertoli-based cell products. Related Document |